{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:49:20Z","timestamp":1793836160348,"version":"4.6.1"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T00:00:00Z","timestamp":1638144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Intestinal microbiota (IM) dysbiosis contributes to the development of autoimmune hepatitis (AIH). This study aimed to investigate the potential effect of fecal microbiota transplantation (FMT) in a murine model of experimental AIH (EAH), a condition more similar to that of AIH patients. Changes in the enteric microbiome were determined in AIH patients and EAH mice. Moreover, we established an experimental model of secondary EAH mice harboring dysbiosis (ABx) to analyze the effects of therapeutic FMT administration on follicular regulatory T (TFR) and helper T (TFH) cell imbalances and IM composition <jats:italic>in vivo<\/jats:italic>. Alterations of the IM composition and bacterial translocation occurred in AIH patients compared to nonalcoholic fatty liver disease patients and healthy controls (HCs). Therapeutic FMT significantly attenuated liver injury and bacterial translocation and improved the imbalance between splenic TFR cells and TFH cells in ABx EAH mice. Furthermore, therapeutic FMT also partially reversed the increasing trend in serum liver enzymes (ALT and AST) of CXCR5\u2212\/\u2212EAH mice on the 28th day. Finally, therapeutic FMT could effectively restore antibiotic-induced IM dysbiosis in EAH mice. Taken together, our findings demonstrated that FMT was capable of controlling hepatitis progression in EAH mice, and the associated mechanism might be involved in the regulation of the TFR\/TFH immune imbalance and the restoration of IM composition.<\/jats:p>","DOI":"10.3389\/fimmu.2021.728723","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T13:37:21Z","timestamp":1638365841000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":45,"title":["Fecal Microbiota Transplantation Controls Progression of Experimental Autoimmune Hepatitis in Mice by Modulating the TFR\/TFH Immune Imbalance and Intestinal Microbiota Composition"],"prefix":"10.3389","volume":"12","author":[{"given":"Ma","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Liwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Jianguo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Changping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Jianping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)62163-1","article-title":"Autoimmune Hepatitis","volume":"382","author":"Heneghan","year":"2013","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2010.09.024","article-title":"Autoimmune Hepatitis, HLA and Extended Haplotypes","volume":"10","author":"Oliveira","year":"2011","journal-title":"Autoimmun Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2016.7","article-title":"The Early Onset of Type 1 Autoimmune Hepatitis has a Strong Genetic Influence: Role of HLA and KIR Genes","volume":"17","author":"Podhorzer","year":"2016","journal-title":"Genes Immun"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12245","article-title":"Tfh and Plasma Cells are Correlated With Hypergamaglobulinaemia in Patients With Autoimmune Hepatitis","volume":"34","author":"Ma","year":"2013","journal-title":"Liver Int"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2019.06.007","article-title":"Exploration the Significance of Tfh and Related Molecules on C57BL\/6 Mice Model of Experimental Autoimmune Hepatitis","volume":"54","author":"Ma","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14997","article-title":"Dysregulated TFR and TFH Cells Correlate With B Cell Differentiation and Antibody Production in Autoimmune Hepatitis","volume":"24","author":"Ma","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s003840050236","article-title":"Abnormal Intestinal Permeability and Microbiota in Patients With Autoimmune Hepatitis","volume":"8","author":"Rui","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i42.9257","article-title":"Factoring the Intestinal Microbiome Into the Pathogenesis of Autoimmune Hepatitis","volume":"22","author":"Czaja","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2017.09.013","article-title":"Intestinal Microbiome and Permeability in Patients With Autoimmune Hepatitis","volume":"31","author":"Wangfeng","year":"2017","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2017.08.005","article-title":"Sodium Butyrate Ameliorates S100\/FCA-Induced Autoimmune Hepatitis Through Regulation of Intestinal Tight Junction and Toll-Like Receptor 4 Signaling Pathway","volume":"190","author":"Jinlu","year":"2017","journal-title":"Immunol Lett"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgx007","article-title":"Microbiota, NASH, HCC and the Potential Role of Probiotics","volume":"38","author":"Brandi","year":"2017","journal-title":"Carcinog"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00061","article-title":"Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-Alcoholic Fatty Liver Disease","volume":"9","author":"Saltzman","year":"2018","journal-title":"Front Microbiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.01.020","article-title":"Interactions Between the Intestinal Microbiome and Liver Diseases","volume":"146","author":"Schnabl","year":"2014","journal-title":"Gastroenterol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/srep36365","article-title":"Enterogenous Bacterial Glycolipids are Required for the Generation of Natural Killer T Cells Mediated Liver Injury","volume":"6","author":"Wei","year":"2016","journal-title":"Sci Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.12968\/hmed.2019.80.10.594","article-title":"Challenges in the Use of Corticosteroids in the Management of Autoimmune Hepatitis","volume":"80","author":"Chapman","year":"2019","journal-title":"Br J Hosp Med (Lond)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.5009\/gnl15352","article-title":"And Management of Autoimmune Hepatitis: Current Status and Future Directions","volume":"10","author":"Czaja. Diagnosis","year":"2016","journal-title":"Gut Liver"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00382","article-title":"Novel Diagnostic and Therapeutic Strategies in Juvenile Autoimmune Hepatitis","volume":"7","author":"Sciveres","year":"2019","journal-title":"Front Pediatr"},{"key":"B18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.trsl.2016.04.009","article-title":"Inflammatory Bowel Disease: Exploring Gut Pathophysiology for Novel Therapeutic Targets","volume":"176","author":"Yadav","year":"2016","journal-title":"Transl Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2016.08.003","article-title":"The Gut Microbiota: A Treasure for Human Health","volume":"34","author":"Li","year":"2016","journal-title":"Biotechnol Adv"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2807\/ese.14.34.19316-en","article-title":"Struggling With Recurrent Clostridium Difficile Infections: Is Donor Faeces the Solution","volume":"14","author":"Van","year":"2009","journal-title":"Euro Surveill"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2017.1293224","article-title":"Fecal Microbiota Transplantation in Metabolic Syndrome: History, Present and Future","volume":"8","author":"De Groot","year":"2017","journal-title":"Gut Microbes"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.8512","article-title":"Fecal Microbiota Transplantation Ameliorates Active Ulcerative Colitis","volume":"19","author":"Chen","year":"2020","journal-title":"Exp Ther Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i1.102","article-title":"Fecal Microbiota Transplantation Broadening its Application Beyond Intestinal Disorders","volume":"21","author":"Xu","year":"2015","journal-title":"World J Gastroenterol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2018.05.003","article-title":"Effects of Ceftriaxone-Induced Intestinal Dysbacteriosis on Dendritic Cells of Small Intestine in Mice","volume":"57","author":"Li","year":"2013","journal-title":"Microbiol Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.7","article-title":"Dysbiosis and the Immune System","volume":"17","author":"Levy","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01548-14","article-title":"Intestinal Dysbiosis Associated With Systemic Lupus Erythematosus","volume":"5","author":"Hevia","year":"2014","journal-title":"Mbio"},{"key":"B27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1136\/gutjnl-2018-317791","article-title":"Fungi Participate in the Dysbiosis of Gut Microbiota in Patients With Primary Sclerosing Cholangitis","volume":"69","author":"Lemoinne","year":"2020","journal-title":"Gut"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e0141717","DOI":"10.1371\/journal.pone.0141717","article-title":"Early-Life Exposure to Clostridium Leptum Causes Pulmonary Immunosuppression","volume":"10","author":"Huang","year":"2015","journal-title":"PloS One"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-13-20","article-title":"Clostridium Leptum Group Bacteria Abundance and Diversity in the Fecal Microbiota of Patients With Inflammatory Bowel Disease: A Case-Control Study in India","volume":"109","author":"Jayakanthan","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/mog.0b013e3282f2b0d7","article-title":"Alterations in Intestinal Microbial Flora and Human Disease","volume":"24","author":"Othman","year":"2008","journal-title":"Curr Opin Gastroenterol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-013-2960-y","article-title":"The Impact of Alcohol Consumption and Cholecystectomy on Small Intestinal Bacterial Overgrowth","volume":"59","author":"Gabbard","year":"2014","journal-title":"Dig Dis Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2015.05.005","article-title":"T Follicular Regulatory Cells in the Regulation of B Cell Responses","volume":"36","author":"Sage","year":"2015","journal-title":"Trends Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jss.2005.10.004","article-title":"Localization and Changes of Diamine Oxidase During Cardiopulmonary Bypass in Rabbits","volume":"131","author":"Tsunooka","year":"2006","journal-title":"J Surg Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.728723\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T13:37:22Z","timestamp":1638365842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.728723\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,29]]},"references-count":33,"alternative-id":["10.3389\/fimmu.2021.728723"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.728723","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,29]]},"article-number":"728723"}}